DARE
Price
$2.06
Change
+$0.02 (+0.98%)
Updated
Sep 23 closing price
Capitalization
27.77M
FGHQF
Price
$0.15
Change
+$0.05 (+50.00%)
Updated
Jul 31 closing price
Capitalization
344.25M
Interact to see
Advertisement

DARE vs FGHQF

Header iconDARE vs FGHQF Comparison
Open Charts DARE vs FGHQFBanner chart's image
Dare Bioscience
Price$2.06
Change+$0.02 (+0.98%)
Volume$77.38K
Capitalization27.77M
Frontage
Price$0.15
Change+$0.05 (+50.00%)
Volume$130
Capitalization344.25M
DARE vs FGHQF Comparison Chart in %
Loading...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FGHQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DARE vs. FGHQF commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DARE is a StrongBuy and FGHQF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (DARE: $2.06 vs. FGHQF: $0.15)
Brand notoriety: DARE and FGHQF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DARE: 35% vs. FGHQF: 1%
Market capitalization -- DARE: $27.77M vs. FGHQF: $344.25M
DARE [@Biotechnology] is valued at $27.77M. FGHQF’s [@Biotechnology] market capitalization is $344.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DARE’s FA Score shows that 0 FA rating(s) are green whileFGHQF’s FA Score has 0 green FA rating(s).

  • DARE’s FA Score: 0 green, 5 red.
  • FGHQF’s FA Score: 0 green, 5 red.
According to our system of comparison, FGHQF is a better buy in the long-term than DARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DARE’s TA Score shows that 3 TA indicator(s) are bullish while FGHQF’s TA Score has 0 bullish TA indicator(s).

  • DARE’s TA Score: 3 bullish, 3 bearish.
  • FGHQF’s TA Score: 0 bullish, 1 bearish.
According to our system of comparison, DARE is a better buy in the short-term than FGHQF.

Price Growth

DARE (@Biotechnology) experienced а -1.67% price change this week, while FGHQF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FGHQF($344M) has a higher market cap than DARE($27.8M). FGHQF has higher P/E ratio than DARE: FGHQF (78.84) vs DARE (0.10). FGHQF YTD gains are higher at: 48.317 vs. DARE (-33.974).
DAREFGHQFDARE / FGHQF
Capitalization27.8M344M8%
EBITDA-17.84MN/A-
Gain YTD-33.97448.317-70%
P/E Ratio0.1078.840%
Revenue-17.7KN/A-
Total Cash5.04MN/A-
Total Debt3.03MN/A-
FUNDAMENTALS RATINGS
DARE: Fundamental Ratings
DARE
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAREFGHQF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 3 days ago
40%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
4%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
4%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 14 days ago
81%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 6 days ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FGHQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIPC40.820.83
+2.08%
Brookfield Infrastructure Corp
CNQ32.140.03
+0.09%
Canadian Natural Resources Limited
FORL11.49N/A
N/A
Four Leaf Acquisition Corp
HSII49.79-0.37
-0.74%
Heidrick & Struggles International
SLSN3.34-0.03
-0.89%
Solesence Inc

DARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, DARE has been closely correlated with CLNN. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if DARE jumps, then CLNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
+0.98%
CLNN - DARE
88%
Closely correlated
-4.38%
PHIO - DARE
81%
Closely correlated
-3.12%
AZTR - DARE
78%
Closely correlated
-2.61%
FGHQF - DARE
45%
Loosely correlated
N/A
MNMD - DARE
44%
Loosely correlated
+4.30%
More

FGHQF and

Correlation & Price change

A.I.dvisor indicates that over the last year, FGHQF has been loosely correlated with DARE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FGHQF jumps, then DARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGHQF
1D Price
Change %
FGHQF100%
N/A
DARE - FGHQF
45%
Loosely correlated
+0.98%
LPCN - FGHQF
28%
Poorly correlated
-3.50%
ARMP - FGHQF
25%
Poorly correlated
+0.99%
LGVN - FGHQF
25%
Poorly correlated
+0.96%
BLTE - FGHQF
25%
Poorly correlated
-0.34%
More